Polish Study Reveals Dangerous Inflammatory and Oxidative Responses in COVID-19 Patients
Nikhil Prasad Fact checked by:Thailand Medical News Team Apr 06, 2025 3 weeks, 1 day, 2 hours, 15 minutes ago
Medical News:
Severe Immune Reactions May Explain Long Term Symptoms and Poor Outcomes in Infected Individuals
A new Polish study has uncovered critical insights into how COVID-19 triggers severe inflammatory reactions and oxidative stress in infected individuals, which could explain the disease’s progression and long-lasting symptoms in many patients.
Conducted by researchers from the Medical University of Silesia in Katowice and Zabrze, including the Departments of Biochemistry, Cardiology, Urology, Ophthalmology, Biophysics, Microbiology and Immunology, the study compared blood samples from individuals previously infected with SARS-CoV-2 and those who had never contracted the virus. The goal was to examine levels of specific immune system molecules and oxidative stress markers that may play key roles in the development of severe COVID-19.
The team found that individuals who had recovered from COVID-19 still had significantly elevated levels of two inflammatory markers: IL-1β (interleukin-1 beta) and IL-1Ra (interleukin-1 receptor antagonist). These molecules are part of the body’s natural immune response but can also fuel harmful inflammation when overproduced. This
Medical News report also found that COVID-19 patients had higher levels of malondialdehyde (MDA), a toxic byproduct of oxidative stress that damages cells and tissues.
Why Cytokines Like IL-1 Are Dangerous
Cytokines are small proteins released by immune cells to regulate inflammation and fight infections. IL-1β, in particular, is known to drive inflammation and has been linked to many autoimmune and autoinflammatory diseases. When present in high amounts, it can trigger a dangerous overreaction known as a cytokine storm, a key feature in many severe COVID-19 cases.
To counteract IL-1β, the body naturally produces IL-1Ra, which blocks its activity. The researchers found that both IL-1β and IL-1Ra were significantly higher in COVID-19 patients. This suggests the immune system was still in a heightened state of alert long after the infection had passed. Such prolonged immune activation is believed to contribute to long COVID and other lingering symptoms such as fatigue, sleep problems, and cardiovascular issues.
The Role of Oxidative Stress
Oxidative stress occurs when harmful molecules known as reactive oxygen species (ROS) build up faster than the body can neutralize them. This imbalance leads to cellular damage and has been associated with numerous chronic conditions, including heart disease and cancer.
Among several markers tested, only MDA levels were significantly elevated in the COVID-19 group. MDA is produced when fats in cell membranes are broken down by ROS, making it a reliable indicator of oxidative damage. Elevated MDA levels could indicate that tissues in the body continue to suffer damage even after the virus is cleared.
Importantly, other oxidative stress indicators such as antioxidant enzyme levels (like SOD and catalase) did not differ significantly between the groups. This points to a specific type of lipid damage being more prevalent in COVID-19, requiring further exploration.
Study Details and Statistical Findings
The study involved 57 vaccinated individuals, divided into two groups - 33 with a
confirmed history of COVID-19 and 24 who had never been infected. All participants were matched for age, gender, body weight, smoking habits, and physical activity to eliminate confounding variables.
Using advanced biochemical testing equipment, researchers found:
-IL-1Ra was significantly higher in COVID-19 patients (median: 214.72 pg/mL vs 166.09 pg/mL in non-infected).
-IL-1β levels were markedly elevated (median: 13.88 pg/mL vs 4.79 pg/mL).
-MDA levels were also higher, confirming oxidative stress presence.
These values were all statistically significant, with p-values below 0.05, confirming a true difference between the infected and non-infected groups.
Implications for Treatment and Recovery
The study reinforces the notion that the harmful effects of COVID-19 extend far beyond the acute infection period. High levels of IL-1β and oxidative stress are not only linked to disease severity but may also underlie the persistent symptoms seen in long COVID patients. This suggests that anti-inflammatory therapies targeting IL-1β (such as anakinra or canakinumab) and antioxidant treatments (like high-dose vitamin C or glutathione) might help reduce complications and speed up recovery.
The researchers referenced studies showing that aspirin, a common anti-inflammatory drug, reduced IL-1Ra levels and improved COVID-19 outcomes. This highlights a potential therapeutic role for repurposed medications.
Conclusion
The findings from this study underscore the importance of monitoring inflammatory markers and oxidative stress in COVID-19 patients even after recovery. Elevated levels of IL-1β, IL-1Ra, and MDA suggest that many individuals may remain in a pro-inflammatory state for months. This could contribute to chronic symptoms and increased risk of other diseases. Targeted treatments that reduce inflammation and oxidative damage might offer hope to those suffering from long COVID.
Healthcare providers should consider these markers when evaluating post-COVID conditions, and future therapies must address both viral clearance and immune modulation to truly end the disease’s grip on global health.
The study findings were published in the peer reviewed Journal of Clinical Medicine
https://www.mdpi.com/2077-0383/14/7/2489
For the latest COVID-19 News, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/scientists-discover-a-highly-conserved-region-in-the-sars-cov-2-spike-protein-that-triggers-harmful-autoantibodies
https://www.thailandmedical.news/news/covid-19-causes-astrogliosis,-long-term-brain-inflammation-and-cellular-damage
https://www.thailandmedical.news/news/sars-cov-2-spike-protein-detected-in-brain-arteries-of-43-8-percent-of-vaccinated-individuals-even-17-months-after-mrna-vaccination
https://www.thailandmedical.news/articles/coronavirus
https://www.thailandmedical.news/pages/thailand_doctors_listings
Share
Tweet
Share
